Literature DB >> 9807666

Bradykinin mediates myocardial ischaemic preconditioning against free radical injury in guinea-pig isolated heart.

Z Q Jin1, X Chen.   

Abstract

1. Myocardial ischaemic preconditioning (IP) against free radical injury and its possible mediator(s) was investigated in a Langendorff-perfused guinea-pig heart. 2. 1,1-Diphenyl-2-picryl-hydrazyl (DPPH) was used for triggering free radical injury in cardiac tissue. It reduced left ventricular developed pressure (LVDP), +/- dp/dtmax, heart rate (HR) and coronary flow (CF) and increased thiobarbituric acid-reactive substances (TBARS) in cardiac tissue. 3. Ischaemic preconditioning (5 min global ischaemia and 5 min reperfusion) exerted cardioprotection against DPPH-induced functional impairment, with significant improvement in LVDP, +/- dp/dtmax, HR and CF. The formation of TBARS in cardiac tissue was reduced. Blockade of bradykinin (BK) B2 receptors with icatibant (HOE 140) abolished the cardio-protective effects of IP. 4. Bradykinin (10(-7) mol/L) perfusion for 10 min protected the heart against free radical injury. The cardioprotection induced by BK was reversed by HOE 140. 5. Pretreatment with IP and BK results in cardiac protection against free radical injury through the activation of B2 receptors. Endogenously generated BK may mediate IP in the guinea-pig heart.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9807666     DOI: 10.1111/j.1440-1681.1998.tb02346.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  4 in total

1.  Conditioned medium from hypoxic cells protects cardiomyocytes against ischemia.

Authors:  B Chanyshev; A Shainberg; A Isak; Y Chepurko; E Porat; E Hochhauser
Journal:  Mol Cell Biochem       Date:  2011-12-08       Impact factor: 3.396

Review 2.  Organ preconditioning: the past, current status, and related lung studies.

Authors:  Shi-ping Luh; Pan-chyr Yang
Journal:  J Zhejiang Univ Sci B       Date:  2006-05       Impact factor: 3.066

3.  Role of the bradykinin B2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury.

Authors:  Danielle G Souza; Vanessa Pinho; Jorge L Pesquero; Eliane S Lomez; Steve Poole; Luiz Juliano; Ary Correa; M Salete de A Castro; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

4.  Bradykinin and angiotensin-converting enzyme inhibition in cardioprotection.

Authors:  G Jancso; Mt Jaberansari; B Gasz; Z Szanto; B Cserepes; E Röth
Journal:  Exp Clin Cardiol       Date:  2004
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.